Crescent Capital BDC (CCAP)
(Delayed Data from NSDQ)
$17.24 USD
0.00 (0.00%)
Updated Apr 25, 2024 04:00 PM ET
2-Buy of 5 2
B Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
CCAP 17.24 0.00(0.00%)
Will CCAP be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CCAP based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CCAP
Crescent Capital BDC (CCAP) Stock Moves -1.05%: What You Should Know
Is It Worth Investing in Crescent Capital BDC (CCAP) Based on Wall Street's Bullish Views?
CCAP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Crescent Capital BDC (CCAP) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks Industry Outlook Highlights Bain Capital Specialty Finance, Barings BDC and Crescent Capital
3 SBIC & Commercial Finance Stocks to Buy Amid Grim Industry Prospects
Other News for CCAP
Crescent Capital: Dividend Coverage Supported By Higher Interest Rates
My 9.5% Income Portfolio - Reinvesting Dividends
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2024 Financial Results
Crescent Capital: Strong Fundamentals And Higher Interest Rates Should Lead To Higher Valuation
Prem Watsa's Strategic Move: A Closer Look at the Crescent Capital BDC Inc Trade